AstraZeneca PLC (FRA:ZEG)
139.50
-1.30 (-0.92%)
At close: Sep 5, 2025
AstraZeneca Employees
AstraZeneca had 94,300 employees as of December 31, 2024. The number of employees increased by 4,400 or 4.89% compared to the previous year.
Employees
94,300
Change (1Y)
4,400
Growth (1Y)
4.89%
Revenue / Employee
€510,187
Profits / Employee
€74,901
Market Cap
215.99B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 94,300 | 4,400 | 4.89% |
Dec 31, 2023 | 89,900 | 6,400 | 7.66% |
Dec 31, 2022 | 83,500 | 400 | 0.48% |
Dec 31, 2021 | 83,100 | 7,000 | 9.20% |
Dec 31, 2020 | 76,100 | 5,500 | 7.79% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
SAP SE | 109,121 |
Siemens Aktiengesellschaft | 327,000 |
Deutsche Telekom AG | 198,194 |
Allianz SE | 156,626 |
Rheinmetall AG | 28,539 |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 44,224 |
Siemens Energy AG | 98,000 |
Deutsche Bank Aktiengesellschaft | 89,753 |
AstraZeneca News
- 19 hours ago - TN signs MoUs with Hinduja, AstraZeneca - The Times of India
- 3 days ago - Sanofi Hit With Shock As Flagship Drug Successor Disappoints Investors - Benzinga
- 3 days ago - AstraZeneca, Corning And More On CNBC's 'Final Trades' - Benzinga
- 3 days ago - Personalis Announces New Data from a Landmark Neoadjuvant Lung Cancer Trial Showing Superiority of Ultra-Sensitive, Tumor-Informed MRD Testing - Wallstreet:Online
- 3 days ago - Global drugmakers rush to boost US presence as tariff threat looms - Reuters
- 3 days ago - Final Trades: AstraZeneca, Corning, the IBIT and the SPHD - CNBC
- 4 days ago - Mineralys (MLYS) Soars 85% After AstraZeneca's Drug Trial Success - GuruFocus
- 4 days ago - Mineralys surges after late-stage trial data AstraZeneca’s blood pressure drug - Seeking Alpha